Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Dec;49(12):E467-E470.
doi: 10.1002/dc.24863. Epub 2021 Aug 25.

COVID-19 post-vaccination lymphadenopathy: Report of cytological findings from fine needle aspiration biopsy

Affiliations
Case Reports

COVID-19 post-vaccination lymphadenopathy: Report of cytological findings from fine needle aspiration biopsy

Nicholas Jin Hong Tan et al. Diagn Cytopathol. 2021 Dec.

Abstract

The coronavirus COVID-19 pandemic has spurred the rapid development of vaccines, with vaccination programmes already underway in many countries. Regional lymphadenopathy is one of the documented side effects of vaccination. We document the fine needle aspiration cytological findings of an enlarged supraclavicular lymph node in a 34-year-old Asian female following the first dose of the Pfizer-BioNTech COVID-19 mRNA vaccine, which appears to be the first such report in a premorbidly well patient with no known history of malignancy. The cytological findings featured a reactive pattern in keeping with follicular hyperplasia, with prominent germinal centre elements including lymphohistiocytic aggregates and tingible-body macrophages. Despite an increased proportion of larger lymphocytes, the overall pattern was in keeping with a reactive pattern, bearing in mind the temporal and geographic relation to the vaccination injection. In instances of localised lymphadenopathy, particularly in supraclavicular or axillary locations, pathologists should be cognizant of the possibility of post-vaccination reactive lymphadenopathy, and seek clinical and radiological hints favouring a benign process, whilst recognising potential morphological overlaps with lymphoproliferative disorders. Awareness of this diagnostic pitfall is especially important as COVID-19 vaccination coverage is ramped up worldwide, leading to an expected increase in incidence of post-vaccination reactive lymphadenopathy.

Keywords: COVID-19; FNA; cytology; lymphadenopathy; post-vaccination.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Cytological findings. (A) A mixed lymphoid population with increased numbers of larger lymphocytes. Hemacolor, ×200. (B) Lymphohistiocytic aggregate from germinal centre, with occasional follicular dendritic cells (thin arrow) and centroblasts (thick arrow). Papanicolaou, ×600. (C) Tingible‐body macrophages (arrows) and increased numbers of large lymphocytes. Hemacolor, ×400. (D) Tingible‐body macrophage (arrow) containing abundant apoptotic debris. Papanicolaou, ×600 [Colour figure can be viewed at wileyonlinelibrary.com]

Similar articles

Cited by

References

    1. Pfizer Inc . Pfizer‐BioNTech COVID‐19 Vaccine EUA Fact Sheet for Recipients and Caregivers [Internet]. FDA; 2021. https://www.fda.gov/media/144414/download.
    1. Studdiford J, Lamb K, Horvath K, Altshuler M, Stonehouse A. Development of unilateral cervical and supraclavicular lymphadenopathy after human papilloma virus vaccination. Pharmacotherapy. 2008;28(9):1194‐1197. - PubMed
    1. Hartsock RJ. Postvaccinial lymphadenitis. Hyperplasia of lymphoid tissue that simulates malignant lymphomas. Cancer. 1968;21(4):632‐649. - PubMed
    1. Özütemiz C, Krystosek LA, Church AL, et al. Lymphadenopathy in COVID‐19 vaccine recipients: diagnostic dilemma in oncology patients. Radiology. 2021;300(1):E296–E300. - PMC - PubMed
    1. Xu G, Lu Y. COVID‐19 mRNA vaccination‐induced lymphadenopathy mimics lymphoma progression on FDG PET/CT. Clin Nucl Med. 2021;46(4):353‐354. - PubMed

Publication types